- Report
- March 2025
- 311 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Report
- August 2023
- 78 Pages
Israel
From €3323EUR$3,500USD£2,803GBP
- Report
- April 2023
- 80 Pages
South Korea
From €4509EUR$4,750USD£3,804GBP
- Report
- May 2023
- 140 Pages
Global
From €4698EUR$4,949USD£3,963GBP
- Report
- November 2022
- 71 Pages
Global
From €4742EUR$4,995USD£4,000GBP
- Report
- November 2022
- 755 Pages
Global
From €9489EUR$9,995USD£8,004GBP
- Report
- November 2019
Global
From €9489EUR$9,995USD£8,004GBP
- Report
- May 2023
- 9 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- May 2021
- 121 Pages
Global
€4509EUR$4,750USD£3,804GBP
The Cardiac Ablation Catheter market is a segment of the Cardiovascular Devices industry. It is composed of medical devices used to treat cardiac arrhythmias, or irregular heartbeats. These catheters are inserted into the heart through a vein in the neck or groin, and then used to ablate, or destroy, the tissue causing the arrhythmia. The catheters are typically made of a flexible material, such as polyurethane, and are equipped with electrodes that deliver radiofrequency energy to the targeted tissue. This energy is used to heat and destroy the tissue, thus restoring the heart's normal rhythm.
The Cardiac Ablation Catheter market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Medtronic, Boston Scientific, Abbott, Biosense Webster, and St. Jude Medical. Show Less Read more